260 related articles for article (PubMed ID: 24005193)
1. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.
Carragee EJ; Chu G; Rohatgi R; Hurwitz EL; Weiner BK; Yoon ST; Comer G; Kopjar B
J Bone Joint Surg Am; 2013 Sep; 95(17):1537-45. PubMed ID: 24005193
[TBL] [Abstract][Full Text] [Related]
2. Bone Morphogenetic Proteins in Spinal Surgery: What Is the Fusion Rate and Do They Cause Cancer?
Malham GM; Giles GG; Milne RL; Blecher CM; Brazenor GA
Spine (Phila Pa 1976); 2015 Nov; 40(22):1737-42. PubMed ID: 26730525
[TBL] [Abstract][Full Text] [Related]
3. Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion.
Glassman SD; Dimar JR; Carreon LY; Campbell MJ; Puno RM; Johnson JR
Spine (Phila Pa 1976); 2005 Aug; 30(15):1694-8. PubMed ID: 16094268
[TBL] [Abstract][Full Text] [Related]
4. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.
Faundez A; Tournier C; Garcia M; Aunoble S; Le Huec JC
Int Orthop; 2016 Jun; 40(6):1309-19. PubMed ID: 26961193
[TBL] [Abstract][Full Text] [Related]
6. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
Burkus JK; Dryer RF; Peloza JH
J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
[TBL] [Abstract][Full Text] [Related]
7. rhBMP-2 for posterolateral instrumented lumbar fusion: a multicenter prospective randomized controlled trial.
Hurlbert RJ; Alexander D; Bailey S; Mahood J; Abraham E; McBroom R; Jodoin A; Fisher C
Spine (Phila Pa 1976); 2013 Dec; 38(25):2139-48. PubMed ID: 24296479
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk from bone morphogenetic protein exposure in spinal arthrodesis.
Kelly MP; Savage JW; Bentzen SM; Hsu WK; Ellison SA; Anderson PA
J Bone Joint Surg Am; 2014 Sep; 96(17):1417-22. PubMed ID: 25187579
[TBL] [Abstract][Full Text] [Related]
9. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
Burkus JK; Gornet MF; Glassman SD; Slosar PJ; Rosner MK; Deckey JE; Nowak J; Hatcher BM
Spine (Phila Pa 1976); 2011 Dec; 36(25):2158-67. PubMed ID: 21325990
[TBL] [Abstract][Full Text] [Related]
10. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
11. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
Boden SD; Kang J; Sandhu H; Heller JG
Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
[TBL] [Abstract][Full Text] [Related]
12. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer.
Sayama C; Willsey M; Chintagumpala M; Brayton A; Briceño V; Ryan SL; Luerssen TG; Hwang SW; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984
[TBL] [Abstract][Full Text] [Related]
13. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
Villavicencio AT; Burneikiene S
Spine J; 2016 Oct; 16(10):1208-1213. PubMed ID: 27343729
[TBL] [Abstract][Full Text] [Related]
14. High-dose rhBMP-2 for adults: major and minor complications: a study of 502 spine cases.
Mesfin A; Buchowski JM; Zebala LP; Bakhsh WR; Aronson AB; Fogelson JL; Hershman S; Kim HJ; Ahmad A; Bridwell KH
J Bone Joint Surg Am; 2013 Sep; 95(17):1546-53. PubMed ID: 24005194
[TBL] [Abstract][Full Text] [Related]
15. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human bone morphogenetic protein-2 versus iliac crest bone graft in anterior cervical discectomy and fusion: Dysphagia and dysphonia rates in the early postoperative period with review of the literature.
Riederman BD; Butler BA; Lawton CD; Rosenthal BD; Balderama ES; Bernstein AJ
J Clin Neurosci; 2017 Oct; 44():180-183. PubMed ID: 28716569
[TBL] [Abstract][Full Text] [Related]
17. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial.
Dawson E; Bae HW; Burkus JK; Stambough JL; Glassman SD
J Bone Joint Surg Am; 2009 Jul; 91(7):1604-13. PubMed ID: 19571082
[TBL] [Abstract][Full Text] [Related]
19. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
[TBL] [Abstract][Full Text] [Related]
20. Longer follow-up continues to reveal no increased risk of cancer with the use of recombinant human bone morphogenetic protein in spine fusion.
Dettori JR; Chapman JR; DeVine JG; McGuire RA; Junge MR; Norvell DC
Spine J; 2019 Oct; 19(10):1640-1647. PubMed ID: 31108234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]